MetLife FY2026 Earnings Forecast Raised by DOWLING & PARTN

MetLife, Inc. (NYSE:MET – Free Report) – Equities researchers at DOWLING & PARTN upped their FY2026 earnings estimates for MetLife in a report issued on Tuesday, October 13th. DOWLING & PARTN analyst J. Hurwitz now forecasts that the financial services provider will post earnings per share of $10.30 for the year, up from their prior forecast of $10.10. The consensus estimate for MetLife’s current full-year earnings is $9.88 per share.

MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 earnings per share.

MET has been the topic of several other reports. Weiss Ratings reiterated a “buy (b)” rating on shares of MetLife in a research report on Friday, September 11th. Bank of America lowered their price objective on shares of MetLife from $106.00 to $103.00 and set a “buy” rating on the stock in a research note on Wednesday, July 15th. TD Cowen boosted their target price on shares of MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, October 5th. UBS Group increased their target price on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, October 6th. Finally, JPMorgan Chase & Co. raised their target price on shares of MetLife from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Thirteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and an average price target of $105.06.

Check Out Our Latest Research Report on MET

MetLife Stock Down 0.9%

Shares of MET stock opened at $99.77 on Thursday. MetLife has a 1 year low of $67.33 and a 1 year high of $101.44. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The business’s fifty day moving average is $96.80 and its 200-day moving average is $88.42. The stock has a market cap of $64.19 billion, a PE ratio of 19.11, a price-to-earnings-growth ratio of 0.95 and a beta of 0.78.

Institutional Trading of MetLife

A number of hedge funds have recently bought and sold shares of the company. CX Institutional lifted its position in shares of MetLife by 1.3% in the 3rd quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock valued at $817,000 after acquiring an additional 115 shares in the last quarter. McGlone Suttner Wealth Management Inc. boosted its stake in MetLife by 0.6% in the 3rd quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock worth $2,108,000 after purchasing an additional 124 shares during the period. Capital Analysts LLC grew its position in MetLife by 0.3% during the 2nd quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock worth $3,238,000 after purchasing an additional 129 shares in the last quarter. Kathmere Capital Management LLC grew its position in MetLife by 2.4% during the 1st quarter. Kathmere Capital Management LLC now owns 5,813 shares of the financial services provider’s stock worth $411,000 after purchasing an additional 136 shares in the last quarter. Finally, Worth Asset Management LLC raised its stake in MetLife by 3.1% during the 2nd quarter. Worth Asset Management LLC now owns 4,551 shares of the financial services provider’s stock valued at $385,000 after purchasing an additional 138 shares during the period. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife announced that its Board of Directors has approved a stock buyback program on Wednesday, August 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to buy up to 4.8% of its shares through open market purchases. Share repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio (DPR) is currently 45.40%.

MetLife Company Profile

(Get Free Report)

MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.

The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.

Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.

Read More

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.